On Tuesday, Amphenol Cl A got an upgrade for its IBD SmartSelect Composite Rating from 94 to 97.
The new score means the company is now outperforming 97% of all stocks in terms of the most important fundamental and technical stock-picking criteria. The market's biggest winners often have a 95 or higher score in the early stages of a new price run, so that's a good starting point when looking for the best stocks to buy and watch.
Amphenol Cl A is now out of buy range after breaking out from a 70.84 entry in a consolidation.
Lean How — And When — To Sell Stocks
The stock has a 95 EPS Rating, which means its recent quarterly and annual earnings growth is outpacing 95% of all stocks.
Its Accumulation/Distribution Rating of C shows a roughly equal amount of buying and selling by institutional investors over the last 13 weeks.
In Q3, the company reported 28% earnings growth. That marks five straight quarters of rising EPS gains. Top line growth climbed 26%, up from 18% in the prior quarter. That marks four consecutive reports with increasing revenue gains.
Amphenol Cl A earns the No. 1 rank among its peers in the Electronics-Parts industry group. Coherent and CTS Corp are also among the group's highest-rated stocks.
